Divalproex Sodium Tablet, Delayed Release
Product Images NDC 51655-365

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 51655-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 01)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 02)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 03)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 04)

FDA Label Image

Image (39cef9df 868d 4963 B0a7 7f146275442f 05)

FDA Label Image

39cef9df 868d 4963 B0a7 7f146275442f 06

UWNICHEM PHARMACEUTICALS (USA). INC. is a pharmaceutical company based in the United States.*

FDA Label Image

Label (51655 365 52 Master Bottle Label Approval Rev A 05 20)

This is a bottle of Divalproex Sodium Delayed Release tablets. Each tablet contains 250 mg of valproex sodium, equivalent to valproic acid. The bottle contains 30 tablets and should be stored at controlled room temperature between 20-25°C (68-77°F). The packaging includes a warning to keep out of reach of children. The tablets are made by Unichem Pharmaceuticals and were repackaged by Northwind Pharmaceuticals in Indianapolis. The lot number is 0000000000 and the expiration is 00/00/0000. Dosage instructions should be found in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.